Literature DB >> 33323073

Geographic and behavioral differences associated with sexually transmitted infection prevalence among Indian men who have sex with men in Chennai and Mumbai.

Steven A Safren1,2, Bella Devaleenal3, Katie B Biello2,3,4, Shruta Rawat5, Beena E Thomas3, Kristen S Regenauer6, Vinoth Balu3, C Andres Bedoya7,8, Alpana Dange5, Sunil Menon9, Conall O'Cleirigh2,7,8, Dicky Baruah5, Vivek Anand5, Luke E Hanna3, Ramesh Karunaianantham3, Rakesh Thorat5, Soumya Swaminathan2,10, Matthew J Mimiaga2,4, Kenneth H Mayer2,8.   

Abstract

India has one of the largest numbers of men who have sex with men (MSM) globally; however, geographic data on sexually transmitted infection (STI) prevalence and associations with sexual behavior are limited. Six-hundred and eight MSM in Chennai and Mumbai underwent screening for a behavioral trial and were assessed for bacterial STIs (syphilis, chlamydia, gonorrhea), HIV, and past-month self-reported condomless anal sex (CAS). Mumbai (37.8%) had a greater prevalence of any STI than Chennai (27.6%) (prevalence ratio [PR] = 1.37, 95% CI: 1.09, 1.73). This pattern also emerged for gonorrhea and chlamydia separately but not syphilis. Conversely, Mumbai MSM reported lower rates of CAS (mean = 2.2) compared to Chennai MSM (mean = 14.0) (mean difference = -11.8, 95% CI: -14.6, -9.1). The interaction of city by CAS on any STI prevalence (PR = 2.09, 95% CI: 1.45, 3.01, p < .0001) revealed that in Chennai, higher rates of CAS were not associated with STI prevalence, but in Mumbai they were (PR = 2.49, 95% CI: 1.65, 3.76, p < .0001). The higher prevalence of bacterial STIs but lower frequency of CAS in Mumbai (versus Chennai), along with the significant interaction of CAS with city on STI rates, suggests that there are either differences in disease burden or differences by city with respect to self-reported assessment of CAS. Regardless, the high prevalence rates of untreated STIs and condomless sex among MSM suggest the need for additional prevention intervention efforts for MSM in urban India.

Entities:  

Keywords:  Gay men; chlamydia infection; gonorrhea; sexual behavior; syphilis

Mesh:

Year:  2020        PMID: 33323073      PMCID: PMC9528997          DOI: 10.1177/0956462420943016

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.456


  15 in total

1.  The social construction of male 'homosexuality' in India: implications for HIV transmission and prevention.

Authors:  S Asthana; R Oostvogels
Journal:  Soc Sci Med       Date:  2001-03       Impact factor: 4.634

2.  The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the Methods for Improving Reproductive Health in Africa study.

Authors:  K K Venkatesh; A van der Straten; H Cheng; E T Montgomery; M N Lurie; T Chipato; G Ramjee; K Blanchard; N S Padian; K H Mayer; G de Bruyn
Journal:  Int J STD AIDS       Date:  2011-04       Impact factor: 1.359

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

4.  Sexually transmitted diseases in men who have sex with men.

Authors:  Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

Review 5.  Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition.

Authors:  Kenneth H Mayer; Kartik K Venkatesh
Journal:  Am J Reprod Immunol       Date:  2011-01-09       Impact factor: 3.886

6.  Genital Human Papillomavirus Infection in Indian HIV-Seropositive Men Who Have Sex With Men.

Authors:  Anantharam Raghavendran; Alexandra L Hernandez; Shelly Lensing; Manu Gnanamony; Rajiv Karthik; Murgesan Sivasubramanian; Rajesh Kannangai; Priya Abraham; Dilip Mathai; Joel M Palefsky
Journal:  Sex Transm Dis       Date:  2017-03       Impact factor: 2.830

7.  A pilot RCT of an intervention to reduce HIV sexual risk and increase self-acceptance among MSM in Chennai, India.

Authors:  Steven A Safren; Beena E Thomas; Kenneth H Mayer; Katie B Biello; Jamuna Mani; Vijaylakshmi Rajagandhi; Murugesan Periyasamy; Soumya Swaminathan; Matthew J Mimiaga
Journal:  AIDS Behav       Date:  2014-10

8.  Sexually transmitted infections and HIV in self reporting men who have sex with men: A two-year study from India.

Authors:  Prabhav Aggarwal; Sonali Bhattar; Satyendra K Sahani; Preena Bhalla; Vijay K Garg
Journal:  J Infect Public Health       Date:  2016-01-08       Impact factor: 3.718

9.  A randomized clinical efficacy trial of a psychosocial intervention to strengthen self-acceptance and reduce HIV risk for MSM in India: study protocol.

Authors:  Matthew J Mimiaga; Beena Thomas; Kenneth H Mayer; Kristen S Regenauer; Alpana Dange; C Andres Bedoya; Shruta Rawat; Vinoth Balu; Conall O'Cleirigh; Katie B Biello; Vivek Anand; Soumya Swaminathan; Steven A Safren
Journal:  BMC Public Health       Date:  2018-07-18       Impact factor: 3.295

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

View more
  1 in total

1.  Strengthening resilience to reduce HIV risk in Indian MSM: a multicity, randomised, clinical efficacy trial.

Authors:  Steven A Safren; Beena Thomas; Katie B Biello; Kenneth H Mayer; Shruta Rawat; Alpana Dange; C Andres Bedoya; Sunil Menon; Vivek Anand; Vinoth Balu; Conall O'Cleirigh; Lynne Klasko-Foster; Dicky Baruah; Soumya Swaminathan; Matthew J Mimiaga
Journal:  Lancet Glob Health       Date:  2021-04       Impact factor: 26.763

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.